latest news releases from the newsroom
Talon Therapeutics, Inc.
Hana Biosciences Presents Marqibo Data At the 49th Annual Meeting of the American Society of Hematology
SOUTH SAN FRANCISCO, Calif., Dec. 8, 2007 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on strengthening the foundation of cancer care, presented results today from both clinical and non-clinical studies of Marqibo(r) (vincristine sulfate injection, OPTISOME(tm)) at the 49th Annual Meeting of the American Society of Hematology (ASH). In an oral session, Deborah A. Thomas, M.D. from the University of Texas M. D. Anderson Cancer Center presented clinical data showing that Marqibo with or without pulse dexamethasone appears to have clinically meaningful activity in heavily pre-treated adults with Acute Lymphoblastic Leukemia (ALL).
Glancy Binkow & Goldberg LLP
Glancy Binkow & Goldberg LLP -- Representing Shareholders of BankAtlantic Bancorp Inc. -- Announces Update to Shareholder Lawsuit -- BBX
LOS ANGELES, Dec. 7, 2007 (PRIME NEWSWIRE) -- Glancy Binkow & Goldberg LLP -- representing shareholders of BankAtlantic Bancorp Inc. -- announces 21 days remaining to move to be a lead plaintiff in the shareholder lawsuit. All persons and institutions who purchased or otherwise acquired the securities of BankAtlantic Bancorp, Inc. ("BankAtlantic" or the "Company") (NYSE:BBX) between November 9, 2005 and October 25, 2007, inclusive (the "Class Period"), may move the Court not later than December 28, 2007, to serve as lead plaintiff; however, you must meet certain legal requirements.
FortuNet Announces Appointment of Chief Financial Officer
LAS VEGAS, Dec. 7, 2007 (PRIME NEWSWIRE) -- FortuNet, Inc. (the "Company") (Nasdaq:FNET) today announced that the Company's Board of Directors (the "Board") unanimously approved the appointment of Kevin A. Karo to the office of Chief Financial Officer, effective January 5, 2008. As previously announced, William R. Jacques Jr., the Company's current Chief Financial Officer, will resign from the office of Chief Financial Officer effective January 4, 2008.
WCI Communities, Inc.
WCI Obtains Bank Covenant Waiver Extension
BONITA SPRINGS, Fla., Dec. 7, 2007 (PRIME NEWSWIRE) -- WCI Communities, Inc. (NYSE:WCI), a leading builder of traditional and tower residences in highly amenitized lifestyle communities, today reported that the limited waiver of performance that was previously granted by its banks has now been extended to January 7, 2008. On November 7, 2007, the Company initially obtained a limited waiver of performance under the Fixed Charge Coverage covenant of the Senior Secured Revolving Credit Agreement (Credit Facility), and the Term Loan Agreement (Term Loan), and this waiver was originally set to expire on December 7, 2007. During the extended waiver timeframe, we expect to finalize discussions regarding the anticipated longer-term amendment that would provide financial flexibility, including modification of the fixed charges coverage covenant, and obtain approval of lenders participating in these facilities.
MFB Corp. Announces Fourth Quarter Earnings
MISHAWAKA, Ind., Dec. 7, 2007 (PRIME NEWSWIRE) -- MFB Corp. (Nasdaq:MFBC), parent company of MFB Financial (the "Bank"), reported today its consolidated financial results on an unaudited basis of $3.2 million or $2.37 diluted earnings per share for the year ended September 30, 2007, an increase from net income of $2.2 million or $1.56 diluted earnings per share for the year ended September 30, 2006. MFB Corp's consolidated net income for the three months ended September 30, 2007 was $457,000 or $0.34 diluted earnings per share compared to $954,000 or $0.69 diluted earnings per share for the same period last year.
A Wonderful Picture Book About Self-Discovery -- New Picture Book Weaves a Fascinating, Lesson-Filled Story About a Boy's 'Extraordinary' Discovery
FAIR OAKS, Calif., Dec. 7, 2007 (PRIME NEWSWIRE) -- It is simply natural for everyone to feel that they are just ordinary and that their future is limited. As we all search for our true purpose and our rightful place in this world, discovering our true potential takes time. It is natural that we compare ourselves with others -- only to discover that we are not the best or the greatest. Just as life moves in an unpredictable manner, we discover our true talents when we least expect it. These lesson-filled themes are set to enchant readers in The Ordinary Extraordinary Boy, an astonishing new picture book by author Kim Tennant.
Hemispherx Biopharma, Inc.
Hemispherx Biopharma Receives Notice of Incomplete New Drug Application (NDA)
PHILADELPHIA, Dec. 7, 2007 (PRIME NEWSWIRE) -- Hemispherx Biopharma, Inc. (AMEX:HEB) announced that it has received notice from the U.S. Food and Drug Administration (FDA) that its NDA submission for Ampligen(r) in Chronic Fatigue Syndrome (CFS), after preliminary review, had been determined to be insufficiently complete to permit a substantive review under 21 CFR 314.101 (d). Specifically eleven deficiencies were noted in the Clinical Section and three in the Pre-Clinical Section. No deficiencies were cited in the Chemistry, Manufacturing and Controls Section (CMC).
National Corn Growers Association
NCGA Optimistic as Senate Advances On Farm Bill
ST. LOUIS, Dec. 7, 2007 (PRIME NEWSWIRE) -- The National Corn Growers Association (NCGA) today thanked the Senate for moving closer to a vote on the 2007 farm bill. Agreement has been reached on the number of amendments to be allowed, and Senate Majority Leader Harry Reid (D-Nev.) has said he expects a vote by the holiday recess "unless something untoward happens."